Genetic Polymorphisms in miR-146a, miR-196a2 and miR-125a Genes and its Association in Prostate Cancer.
Genotyping
Haplotypes
Prostate cancer
microRNA
Journal
Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
05
05
2017
accepted:
07
03
2018
pubmed:
30
3
2018
medline:
15
12
2020
entrez:
30
3
2018
Statut:
ppublish
Résumé
The increase in incidence of prostate cancer in the Indian Population stresses the need to identify genetic markers for susceptibility and prognosis. Recent studies show that microRNAs play an important role in tumorigenesis by altering proliferation, differentiation and cell death. Gene polymorphisms not only in promoter region but also within miRNA gene have been shown to affect expression. The present study was aimed to analyze the role of miR-146a, miR-196a2 and miR-125a gene polymorphisms in prostate cancer. Genotyping of three SNPs rs73318382, rs57095329, rs2910164 in miRNA146a, rs11614913 in miR-196a2 and rs41275794, rs12976445, rs10404453 and rs1297533 in miR-125a was performed in 100 cases and 100 controls. Statistical analysis revealed the heterozygous AG genotype of the rs57095329 was significantly decreased in the cases when compared to the controls (OR-0.45, CI -0.24 to 0.85, p value-0.02) indicating an inverse association of this genotype with prostate cancer. Further the heterozygous CT of miR-196a2 (rs11614913) (OR-1.88, CI-1.06 to 3.35, p-0.02) and homozygous CC of miR-125a (rs12976445) (OR-2.55, CI -1.15 to 4.65, p-0.03) showed increased risk for prostate cancer. Combined analysis of all the genotypes revealed that the haplotype combination AGGCGTGG (OR = 0.09 at CI 95% (0.01-0.65) showed an inverse association with prostate cancer. Stratified analysis based on the age and tumor grade revealed no significant association.
Identifiants
pubmed: 29594807
doi: 10.1007/s12253-018-0412-x
pii: 10.1007/s12253-018-0412-x
doi:
Substances chimiques
Biomarkers, Tumor
0
MIRN125 microRNA, human
0
MIRN146 microRNA, human
0
MIRN196 microRNA, human
0
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
193-200Subventions
Organisme : Department of Biotechnology , Ministry of Science and Technology
ID : 6242-P58/RGCB/PMD/DBT/VVSL/2015
Références
Cancer Res. 2005 Aug 15;65(16):7065-70
pubmed: 16103053
J Biol Chem. 2007 Jan 12;282(2):1479-86
pubmed: 17110380
Sci Rep. 2016 Jan 25;6:19825
pubmed: 26805933
Mol Cancer. 2007 Sep 25;6:60
pubmed: 17894887
Science. 2001 Oct 26;294(5543):853-8
pubmed: 11679670
DNA Cell Biol. 2012 Mar;31(3):350-4
pubmed: 21815818
Mol Biol Rep. 2011 Mar;38(3):1609-15
pubmed: 20842445
Prostate. 2012 Aug 1;72(11):1171-8
pubmed: 22161865
Anticancer Res. 2013 Aug;33(8):3233-9
pubmed: 23898084
PLoS Genet. 2011 Jun;7(6):e1002128
pubmed: 21738483
Nat Rev Cancer. 2006 Apr;6(4):259-69
pubmed: 16557279
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Biochem Soc Trans. 2008 Dec;36(Pt 6):1211-5
pubmed: 19021527
Hum Mutat. 2009 Jan;30(1):79-84
pubmed: 18634034
Mol Cancer. 2006 Jun 19;5:24
pubmed: 16784538
Clin Chim Acta. 2010 Sep 6;411(17-18):1287-90
pubmed: 20488170
Genome Res. 2004 Oct;14(10A):1902-10
pubmed: 15364901
PLoS One. 2012;7(6):e40169
pubmed: 22768249
Oncoscience. 2014 Apr 30;1(4):250-261
pubmed: 25594017
RNA. 2008 Mar;14(3):417-24
pubmed: 18174313
J Cancer Res Clin Oncol. 2013 Aug;139(8):1405-10
pubmed: 23728616
Cancer Res. 2007 Jul 1;67(13):6130-5
pubmed: 17616669
Prostate. 2010 Apr 1;70(5):467-72
pubmed: 19902466
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Cancer Res. 2009 Jul 15;69(14):5970-7
pubmed: 19567675
Bioinformatics. 2006 Aug 1;22(15):1928-9
pubmed: 16720584
J Cell Mol Med. 2011 Jan;15(1):14-23
pubmed: 21091634
Prostate. 2014 Dec;74(16):1613-21
pubmed: 25214035
Int J Endocrinol. 2015;2015:802562
pubmed: 26664358
Asian Pac J Cancer Prev. 2012;13(12):6245-50
pubmed: 23464439
Mutagenesis. 2012 Nov;27(6):779-88
pubmed: 22952151